4/24/2013

Medtronic will work with ARCA biopharma on a clinical study to test the latter's Gencaro heart failure drug in patients with atrial fibrillation. The trial, which will involve 200 patients, will use Medtronic's device designed to monitor abnormal heart rhythms.

Related Summaries